合成生物学的全球市场
市场调查报告书
商品编码
1545634

合成生物学的全球市场

Synthetic Biology: Global Markets

出版日期: | 出版商: BCC Research | 英文 137 Pages | 订单完成后即时交付

价格

预计到 2029年终,全球合成生物学市场规模将达到 616 亿美元,预测期内复合年增长率为 26.1%,从 2023 年的 154 亿美元到 2024 年的 193 亿美元。

预计到 2029年终,赋能产品产业将从 2024 年的 101 亿美元增加到 348 亿美元,复合年增长率为 28.0%。此外,赋能产品领域预计将从 2024 年的 68 亿美元成长到 2029年终的210 亿美元,复合年增长率为 25.1%。

该报告调查了全球合成生物学市场,并提供了市场概况、市场影响因素和市场机会、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区的分析。分析、竞争格局、主要企业概况等。

目录

第一章执行摘要

  • 市场展望
  • 调查范围
  • 市场概况

第二章 市场概况

  • 概述
  • 价值链分析
  • 法律规范
  • 美国创业板监管
  • 合成生物学对生物多样性保育的影响
  • 直接影响
  • 间接影响

第三章市场动态

  • 概述
  • 市场驱动因素
  • 合成生物学在各领域的应用
  • 扩大研发资金
  • 降低 DNA定序序成本
  • 合成生物学的持续创新
  • 市场限制因素
  • 生物安全、生物安保和伦理问题
  • 市场机会
  • 对替代燃料的需求增加
  • 在合成生物学中利用机器学习

第四章 新趋势及专利分析

  • 新趋势
  • CRISPR-Cas系统
  • 基因驱动
  • 扩充遗传密码
  • 光遗传学
  • 合成基因组学
  • 无细胞系统
  • 微生物组工程
  • 专利分析
  • 主要授权专利
  • 专利审查

第五章市场区隔分析

  • 细分细分
  • 市场分析:依产品类型
  • 启用的产品
  • 赋能产品
  • 生物成分
  • 综合系统
  • 市场分析:按最终用户
  • 启用的产品:按最终用户
  • 由最终用户启用产品
  • 生物成分:依最终使用者分类
  • 整合系统:由最终用户
  • 地域分布
  • 市场分析:按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他领域

第六章 竞争讯息

  • 企业市场占有率分析
  • 工业投资

第七章 合成生物学市场的永续性:ESG 视角

  • 概述
  • 生物科技产业的ESG趋势
  • ESG风险与挑战
  • ESG观点
  • 环境影响
  • 社会影响
  • 管治和道德考虑

第8章附录

  • 调查方法
  • 来源
  • 缩写词
  • 公司简介
  • AGILENT TECHNOLOGIES INC.
  • AMYRIS
  • CODEXIS INC.
  • EUROFINS SCIENTIFIC
  • GENSCRIPT
  • GINKGO BIOWORKS
  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC INC.
  • TWIST BIOSCIENCE
  • VIRIDOS
Product Code: BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

The global synthetic biology market for enabled products is projected to grow from $10.1 billion in 2024 to $34.8 billion by the end of 2029, at a CAGR of 28.0% from 2024 through 2029.

The global synthetic biology market for enabling products is projected to grow from $6.8 billion in 2024 to $21.0 billion by the end of 2029, at a CAGR of 25.1% from 2024 through 2029.

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.

By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes:

50 data tables and 45 additional tables

  • An analysis of the global markets for synthetic biology products and technologies
  • Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
  • Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors

Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies

  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
  • An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
  • Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
  • Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Value Chain Analysis
  • Regulatory Framework
  • Regulation of GEMs in the United States
  • Impacts of Synthetic Biology on Biodiversity Conservation
  • Direct Impacts
  • Indirect Impacts

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Various Applications of Synthetic Biology in Diverse Fields
  • Increasing Funding for Research and Development
  • Declining Cost of DNA Sequencing
  • Continuous Innovations in the Synthetic Biology Field
  • Market Restraints
  • Biosafety, Biosecurity, and Ethical Issues
  • Market Opportunities
  • Increasing Demand for Fuel Alternatives
  • Use of Machine Learning in Synthetic Biology

Chapter 4 Emerging Trends and Patent Analysis

  • Emerging Trends
  • CRISPR-Cas Systems
  • Gene Drives
  • Expanded Genetic Code
  • Optogenetics
  • Synthetic Genomics
  • Cell-Free System
  • Microbiome Engineering
  • Patent Analysis
  • Select Patent Grants
  • Patent Review

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Analysis, by Product Type
  • Enabled Products
  • Enabling Products
  • Biologic Components
  • Integrated Systems
  • Market Analysis, by End User
  • Enabled Product, by End User
  • Enabling Product, by End User
  • Biologic Components, by End User
  • Integrated Systems, by End User
  • Geographic Breakdown
  • Market Analysis, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Company Share Analysis
  • Investment in Industry

Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective

  • Overview
  • ESG Trends in the Biotechnology Industry
  • ESG Risks and Challenges
  • ESG Perspective
  • Environmental Impact
  • Social Impact
  • Governance and Ethical Considerations

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • AMYRIS
  • CODEXIS INC.
  • EUROFINS SCIENTIFIC
  • GENSCRIPT
  • GINKGO BIOWORKS
  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC INC.
  • TWIST BIOSCIENCE
  • VIRIDOS

List of Tables

  • Summary Table : Global Market for Synthetic Biology, by Product Type, Through 2029
  • Table 1 : Challenges and Opportunities Posed by Synthetic Biology
  • Table 2 : Applications of SynBio in Various Aspects
  • Table 3 : Cost of Sequencing a Single Human Genome, 2001-2022
  • Table 4 : Applications of ML/DL in SynBio
  • Table 5 : List of Selected Patents Filed for Synthetic Biology, 2020
  • Table 6 : List of Selected Patents Filed for Synthetic Biology, 2021
  • Table 7 : List of Selected Patents Filed for Synthetic Biology, 2022
  • Table 8 : List of Selected Patents Filed for Synthetic Biology, 2023
  • Table 9 : List of Selected Patents Filed for Synthetic Biology, 2024
  • Table 10 : Top IPCR Codes and Their Descriptions
  • Table 11 : Global Synthetic Biology Market, by Product Type, Through 2029
  • Table 12 : Biodiesel Fuel Performance Comparison, 2024
  • Table 13 : Artemisinin Drug Production Comparison, 2024
  • Table 14 : Global Synthetic Biology Market for Enabled Products, by Region, Through 2029
  • Table 15 : Global Synthetic Biology Market for Enabling Products, by Product Type, Through 2029
  • Table 16 : Global Synthetic Biology Market for Enabling Products, by Region, Through 2029
  • Table 17 : Global Synthetic Biology Market for Biologic Components, by Product Type, Through 2029
  • Table 18 : Global Synthetic Biology Market for Biologic Components, by Region, Through 2029
  • Table 19 : Global Synthetic Biology Market for Integrated Systems, by Product Type, Through 2029
  • Table 20 : Global Synthetic Biology Market for Integrated Systems, by Region, Through 2029
  • Table 21 : Global Synthetic Biology Market, by End User, Through 2029
  • Table 22 : Global Synthetic Biology Enabled Product Market, by End User, Through 2029
  • Table 23 : Global Synthetic Biology Healthcare Market, by Sector, Through 2029
  • Table 24 : Global Synthetic Biology Consumer Products Market, by Sector, Through 2029
  • Table 25 : Global Synthetic Biology Food and Beverage Market, by Sector, Through 2029
  • Table 26 : Factors for Synthetic Biology-Based Chemical Processes
  • Table 27 : Global Synthetic Biology Industrial Chemicals Market, by Sector, Through 2029
  • Table 28 : Global Synthetic Biology Agriculture Market, by Sector, Through 2029
  • Table 29 : Global Synthetic Biology Enabling Product Market, by End User, Through 2029
  • Table 30 : Global Synthetic Biology Biologic Component Market, by End User, Through 2029
  • Table 31 : Global Synthetic Biology Integrated Systems Market, by End User, Through 2029
  • Table 32 : Global Synthetic Biology Market, by Region, Through 2029
  • Table 33 : North American Funding Organizations
  • Table 34 : North American Synthetic Biology Market, by Country, Through 2029
  • Table 35 : North American Synthetic Biology Market, by Product Type, Through 2029
  • Table 36 : U.S. Synthetic Biology Market, by Product Type, Through 2029
  • Table 37 : Canadian Synthetic Biology Market, by Product Type, Through 2029
  • Table 38 : Mexican Synthetic Biology Market, by Product Type, Through 2029
  • Table 39 : European Synthetic Biology Market, by Country, Through 2029
  • Table 40 : European Synthetic Biology Market, by Product Type, Through 2029
  • Table 41 : German Synthetic Biology Market, by Product Type, Through 2029
  • Table 42 : U.K. Synthetic Biology Market, by Product Type, Through 2029
  • Table 43 : French Synthetic Biology Market, by Product Type, Through 2029
  • Table 44 : Spanish Synthetic Biology Market, by Product Type, Through 2029
  • Table 45 : Italian Synthetic Biology Market, by Product Type, Through 2029
  • Table 46 : Rest of the European Synthetic Biology Market, by Product Type, Through 2029
  • Table 47 : Asia-Pacific Synthetic Biology Market, by Country, Through 2029
  • Table 48 : Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
  • Table 49 : Chinese Synthetic Biology Market, by Product Type, Through 2029
  • Table 50 : Japanese Synthetic Biology Market, by Product Type, Through 2029
  • Table 51 : Indian Synthetic Biology Market, by Product Type, Through 2029
  • Table 52 : South Korean Synthetic Biology Market, by Product Type, Through 2029
  • Table 53 : Rest of Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
  • Table 54 : Rest of the World Synthetic Biology Market, by Product Type, Through 2029
  • Table 55 : Selected Major Companies in Synthetic Biology, by Application, 2024
  • Table 56 : Report Information Sources
  • Table 57 : Glossary of Terms Used in the Global Synthetic Biology Market
  • Table 58 : Agilent Technologies Inc.: Company Snapshot
  • Table 59 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 60 : Agilent Technologies Inc.: Product Portfolio
  • Table 61 : Agilent Technologies Inc.: News/Key Developments, 2023
  • Table 62 : Amyris: Company Snapshot
  • Table 63 : Amyris: Product Portfolio
  • Table 64 : Amyris: News/Key Developments, 2021-2023
  • Table 65 : Codexis Inc.: Company Snapshot
  • Table 66 : Codexis Inc.: Financial Performance, FY 2022 and 2023
  • Table 67 : Codexis Inc.: Product Portfolio
  • Table 68 : Codexis Inc.: News/Key Developments, 2022
  • Table 69 : Eurofins Scientific: Company Snapshot
  • Table 70 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
  • Table 71 : Eurofins Scientific: Product Portfolio
  • Table 72 : Eurofins Scientific: News/Key Developments, 2021-2023
  • Table 73 : GenScript: Company Snapshot
  • Table 74 : GenScript: Financial Performance, FY 2022 and 2023
  • Table 75 : GenScript: Product Portfolio
  • Table 76 : GenScript: News/Key Developments, 2021-2024
  • Table 77 : Ginkgo Bioworks: Company Snapshot
  • Table 78 : Ginkgo Bioworks: Financial Performance, FY 2022 and 2023
  • Table 79 : Ginkgo Bioworks: Product Portfolio
  • Table 80 : Ginkgo Bioworks: News/Key Developments, 2022-2024
  • Table 81 : Merck KGaA: Company Snapshot
  • Table 82 : Merck KGaA: Financial Performance, FY 2022 and 2023
  • Table 83 : Merck KGaA: Product Portfolio
  • Table 84 : Merck KGaA: News/Key Developments, 2022-2024
  • Table 85 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 86 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 87 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 88 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
  • Table 89 : Twist Bioscience: Company Snapshot
  • Table 90 : Twist Bioscience: Financial Performance, FY 2022 and 2023
  • Table 91 : Twist Bioscience: Product Portfolio
  • Table 92 : Viridos: Company Snapshot
  • Table 93 : Viridos: Product Portfolio
  • Table 94 : Viridos: News/Key Developments, 2022-2023

List of Figures

  • Summary Figure : Global Market for Synthetic Biology, by Product Type, 2021-2029
  • Figure 1 : Value Chain Analysis: Synthetic Biology Market
  • Figure 2 : Synthetic Biology: Value-Added Chain
  • Figure 3 : Chart Outlining U.S. Regulatory Agencies that Regulate Specific GEMs
  • Figure 4 : Market Dynamics of Synthetic Biology Industry
  • Figure 5 : Funding in Synthetic Biology Sector, 2009-2020
  • Figure 6 : Global Biofuel Demand, Trends and Projections, 2016-2028
  • Figure 7 : Patents Documented, by Legal Status, 2020-2024
  • Figure 8 : Top IPCR Classification Codes, 2020-2024
  • Figure 9 : Global Synthetic Biology Market Share, by Product Type, 2023
  • Figure 10 : Global Synthetic Biology Market Share for Enabled Products, by Region, 2023
  • Figure 11 : Global Synthetic Biology Market Share for Enabling Products, by Product Type, 2023
  • Figure 12 : Global Synthetic Biology Market Share for Enabling Products, by Region, 2023
  • Figure 13 : Global Synthetic Biology Market Share for Biologic Components, by Product Type, 2023
  • Figure 14 : Global Synthetic Biology Market Share for Biologic Components, by Region, 2023
  • Figure 15 : Global Synthetic Biology Market Share for Integrated Systems, by Product Type, 2023
  • Figure 16 : Global Synthetic Biology Market Share for Integrated Systems, by Region, 2023
  • Figure 17 : Global Synthetic Biology Market Share, by End User, 2023
  • Figure 18 : Global Synthetic Biology Enabled Product Market Share, by End User, 2023
  • Figure 19 : Global Synthetic Biology Healthcare Market Share, by Sector, 2023
  • Figure 20 : Global Synthetic Biology Consumer Products Market Share, by Sector, 2023
  • Figure 21 : Global Synthetic Biology Food and Beverage Market Share, by Sector, 2023
  • Figure 22 : Global Synthetic Biology Industrial Chemicals Market Share, by Sector, 2023
  • Figure 23 : Global Synthetic Biology Agriculture Market Share, by Sector, 2023
  • Figure 24 : Global Synthetic Biology Enabling Product Market Share, by End User, 2023
  • Figure 25 : Global Synthetic Biology Biologic Component Market Share, by End User, 2023
  • Figure 26 : Global Synthetic Biology Integrated Systems Market Share, by End User, 2023
  • Figure 27 : Global Synthetic Biology Market Share, by Region, 2023
  • Figure 28 : North American Synthetic Biology Market Share, by Country, 2023
  • Figure 29 : European Synthetic Biology Market Share, by Country, 2023
  • Figure 30 : Asia-Pacific Synthetic Biology Market Share, by Country, 2023
  • Figure 31 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 32 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 33 : Codexis Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 34 : Codexis Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 35 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
  • Figure 36 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
  • Figure 37 : GenScript: Revenue Share, by Business Unit, FY 2023
  • Figure 38 : GenScript: Revenue Share, by Country/Region, FY 2023
  • Figure 39 : Ginkgo Bioworks: Revenue Share, by Business Unit, FY 2023
  • Figure 40 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
  • Figure 41 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
  • Figure 42 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 43 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 44 : Twist Bioscience: Revenue Share, by Business Unit, FY 2023
  • Figure 45 : Twist Bioscience: Revenue Share, by Country/Region, FY 2023